In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has history on its side.

CP-506 is under clinical development by Convert Pharmaceuticals and currently in Phase II for Pancreatic Cancer.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Minneapolis native and Air Force veteran Derek Ronning passed away on Dec. 17, after a fight against pancreatic cancer. The ...

Autonomix Medical shares were up 24% to $4.10 after the company said it received a patent from the U.S. Patent and Trademark Office.

Pancreatic cancer can often be halted, but it's rarely detected in time.The largest gland in the human body produces enzymes and hormones that are vital for digestion and metabolism. However, it is ...

Jimmy Carter was the oldest of four children in his family before his death on Dec. 29, 2024. Here’s everything to know about ...

Turner, who played 245 games for the Cats in the VFL between 1974 and 1988, passed away peacefully on Monday following a ...

Fatboy Slim has revealed he no longer feels the spark for producing new music. The DJ, real name Norman Cook, 60, whose mother passed away this week, shared during his Butlin's All Back to Minehead ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the ...

“Mick passed away today at the Lorne Hospital after a two-year battle with pancreatic cancer,” the club said in a statement. ...